Current practice in preoperative therapy and surgical management of locally advanced rectal cancer: A bi-national survey

Colorectal Disease

Volumn 14, Issue 7, 2012, Pages 814-820

  Ooi, K ^a   Frizelle, F ^b   Ong, E ^a   Faragher, I ^a  

^a Western Hospital   (Australia)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Colorectal surgeon; Combined modality therapy; Magnetic resonance imaging; NHMRC guidelines; Rectal cancer

Indexed keywords

ADVANCED CANCER; ARTICLE; AUSTRALIA; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; HEALTH CARE SURVEY; HIGH RISK PATIENT; HUMAN; ILEOSTOMY; NEW ZEALAND; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SURGEON;

AUSTRALIA; GUIDELINE ADHERENCE; HUMANS; ILEOSTOMY; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 84862148340     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02813.x     Document Type: Article

References (33)

1. Australian Institute of Health and Welfare. Cancer in Australia; an overview 2008. ISSN1039-3307; ISBN-139781740248686; AIHW cat. No.CAN42, 19 December 2008.
2. Frizelle F. Improvement in outcome of rectal cancer in New Zealand. N Z Med J 2003; 116: 492.
3. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal Cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-9.
4. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Eng J Med 2006; 355: 1114-26.
5. Anonymous. Improved survival with pre-operative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 638-46.
6. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
7. Sauer R, Becker H, Hohenberger W et al. Preoperative vs postoperative chemotherapy for rectal cancer. N Eng J Med 2004; 351: 1731-41.
8. Moore HG, Guillem JG. Multimodality management of locally advanced rectal cancer. Am Surg, 2003; 69: 612-9.
9. Moser L, Ritz JP, Hinkelbein W, Hocht S. Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer - a review focusing on open questions. Int J Colorectal Dis 2008; 23: 227-36.
10. Health Insurance (Diagnostic Imaging Service Table) Regulations 2009. (2010) Select Legislative Instrument 2009 No. 271 as Amended made under the Health Insurance Act 1973. Office of Legislative Drafting and Publishing, Attorney-General's department, Canberra.
11. Swellengrebel HA, Marijnen CA, Verwaal VJ et al. Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer. Br J Surg 2011; 98: 418-26.
12. Shihab OC, Brown G, Daniels IR, Heald RJ, Quirke P, Moran BJ. Patients with low rectal cancer treated by abdominoperineal excision have worse tumours and higher involved margin rates compared with patients treated with anterior resection. Dis Colon Rectum 2010; 53: 53-6.
13. Australian Government, National Health and Medical Research Council (NHMRC). Clinical practice guidelines of the prevention, early detection and management of colorectal cancer. The Cancer Council Australia/Australian Cancer Network, December 2005. ISBN: 0-9775060-1-0.
14. Frizelle FA (Ed), New Zealand Guidelines Group (NZGG). (2011) Clinical Guidelines for the Management of early Colorectal Cancer. Wellington, New Zealand.
15. The Association of Coloproctology of Great Britain and Ireland. (2007 3rd edition) Guidelines for the Management of Colorectal Cancer. The Royal College of Surgeons of England, London, UK.
16. Tjandra JJ, Kilkenny JW, Buie D et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2005; 48: 411-23.
17. Gibbs P, Chao MW, Tjandra JJ. Optimizing the outcome for patients with rectal cancer. Dis Colon Rectum 2003; 46: 389-402.
18. Skandarajah AR, Tjandra JJ. Preoperative loco-regional imaging in rectal cancer. ANZ J Surg 2006; 76: 497-504.
19. Beets-Tan RGH, Beets GL. Rectal cancer: how accurate can imaging predict the T-stage and the circumferential resection margin? Int J Colorectal Dis 2003; 18: 385-91.
20. Koh DM, Brown G, Husband JE. Nodal staging in rectal cancer. Abdom Imaging 2006; 31: 652-9.
21. Tytherleigh MG, Ng VV, Pittathankal AA, Wilson MJ, Farouk R. Preoperative staging of rectal cancer by magnetic resonance imaging remains an imprecise tool. ANZ J Surg 2008; 78: 194-8.
22. Eriksen MT, Wibe A, Haffner J, Wiig JN. Norwegian Rectal Cancer Group. Prognostic groups in 1, 676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 2006; 50: 156-67.
23. Taylor FGM, Quirke P, Heald RJ et al. One millimetre is the safe cur-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg 2011; 98: 872-9.
24. Taylor FGM, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. Am J Roentgenol 2008; 191: 1827-35.
25. Marr B, Birbeck K, Garvican J et al. The modern abdomino-perineal excision: the next challenge after total mesorectal excision. Ann Surg 2005; 242: 74-82.
26. Steel MCA, Woods R, Mackay JM, Chen F. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg 2002; 72: 483-7.
27. Den Dulk M, Marijnen CAM, Collette L et al. Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg 2009; 96: 1066-75.
28. McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 2005; 92: 1150-4.
29. Karanjia ND, Corder AP, Bearn P, Heald RJ. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg, 1994; 81: 1224-6.
30. Peeters KC, Marijnen CA, Nagtegaal ID et al. The TME trial after a median follow-up of 6years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
31. Sebag-Montefiore D, Stephens RJ, Steele R et al. Pre-operative radiotherapy vs selective post-operative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): Multicentre, randomised trial. Lancet 2009; 373: 811-20.
32. Ngan S, Fisher R, Goldstein D et al. A randomised trial comparing local recurrence rates between short-course and long-course preoperative radiotherapy for clinical T3 rectal cancer: An Intergroup Trial (TROG, AGITG, CSSANZ, RACS). J Clin Oncol 2010; 28(SUPPL 15): 3509.
33. Taylor FGM, Quirke P, Heald RJ et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis Stage I, II, and III rectal cancer best managed by surgery alone: a prospective multicenter European study. Ann Surg 2011; 253: 711-9.